Latest News in the pharma Industry
All
Thermo Fisher to invest more than $475 million this year on capacity and capability expansion
23 Mar 2020
Thermo Fisher Scientific will invest more than USD475 million in 2020 in new capabilities and capacity to meet increasing demand for biologics, cell and gene therapies and drug products, the contract development and manufacturing organisation said Mond...
Read more
What impact will coronavirus have on pharma supply chains?
23 Mar 2020
Our content has now moved to our new Global Pharma Insights website, providing the very latest news and information covering all aspects of the pharmaceutical supply chain. Please click the link below to access this article.
Read more.jpg)
Codexis and Takeda collaborate to advance novel gene therapies
23 Mar 2020
Partnership to leverage Codexis’ protein engineering platform for the discovery and development of novel transgenes for lysosomal storage disorders and blood factor deficiencies.
Read more.jpg)
Lonza's new medium boosts and optimizes AAV production in insect cells
23 Mar 2020
The TheraPEAK SfAAV Medium is specifically designed to support the development of safe, scalable, gene therapies.
Read more.jpg)
Helsinn receives European approval of its IV formulation of Akynzeo
23 Mar 2020
The new formulation offers patients in Europe an alternative route of administration of the only fixed antiemetic combination targeting two distinct CINV pathways in a single dose.
Read more
FDB to triple UK microbial production capacity as Fujifilm commits to $83 million investment
19 Mar 2020
Fujifilm Diosynth Biotechnologies will triple microbial production capacity at its UK Teesside facility after joint owner Fujifilm Corporation pledged to invest 9 billion yen (USD83 million) in the biologics focused CDMO.
Read more
Oxford Biomedica signs LSA with Juno Therapeutics
19 Mar 2020
Cell and gene focused CDMO Oxford Biomedica (OXB) has signed a licence and clinical supply agreement which could be worth up to USD227 million with Juno Therapeutics, the firms announced Wednesday.
Read more
Univercells launches new cell and gene focused CDMO Exothera
19 Mar 2020
A new contract development and manufacturing organisation to support cell and gene developers with process development and production of viral vectors has been launched by bioprocessing provider Univercells.
Read more
Fujifilm Diosynth Biotechnologies appoints Christine Vannais COO of North Carolina site
17 Mar 2020
Fujifilm Diosynth Biotechnologies has appointed Christine Vannais as chief operating officer at its North Carolina site, the biologics focused CDMO said Monday.
Read more.jpg)
CPhI announces new pharma events calendar for 2020
17 Mar 2020
Organizers secure three new dates for events in Japan, South East Asia and North America in response to COVID-19.
Read more.jpg)
Vaxxas HD-MAP to deliver vaccines directly to the skin
17 Mar 2020
Company awarded US$5 million grant for clinical study of measles and rubella vaccination using Vaxxas’ high-density, micro-array patch.
Read more.jpg)
Haselmeier receives medical device Master File Number for its injection pen systems
17 Mar 2020
This documentation will enable customers worldwide to leverage the D-Flex disposable pen system for their combination product development.
Read more